Morgan Stanley’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Morgan Stanley’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-807,361	Closed	-$140M	–	6991
2015 Q1	$140M	Sell	807,361 -763,198	-49%	-$112M	0.05%	394
2014 Q4	$181M	Buy	1,570,559 +1,287,383	+455%	+$156M	0.07%	313
2014 Q3	$44.2M	Buy	283,176 +188,528	+199%	+$27.3M	0.02%	885
2014 Q2	$11.7M	Sell	94,648 -111,289	-54%	-$12.3M	﹤0.01%	1885
2014 Q1	$21.3M	Buy	205,937 +114,470	+125%	+$11.7M	0.01%	1317
2013 Q4	$8.23M	Buy	91,467 +25,819	+39%	+$2.06M	﹤0.01%	2101
2013 Q3	$4.39M	Sell	65,648 -33,196	-34%	-$2.29M	﹤0.01%	2560
2013 Q2	$6.54M	Buy	+98,844	New	+$5.65M	﹤0.01%	2082

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Morgan Stanley's SLXP Position: Q2 2015 in Review

Morgan Stanley sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 807,361 shares — an estimated $140M sold.

Morgan Stanley first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $181M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Morgan Stanley reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Morgan Stanley sold 807,361 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $140M.
Morgan Stanley first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Morgan Stanley's SALIX PHARMACEUTICALS LTD DEL position peaked at $181M in Q4 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.